Announcement

Collapse
No announcement yet.

Research Study Tecfidera, Gilenya Arbagio

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Research Study Tecfidera, Gilenya Arbagio

    In April I will have my last Tysabri infusion. 30 days later I will switch to Arbagio.

    The DMT switch from Ty to Arbagio is part of a research study of the 3 oral MS meds, Tecfidera, Gilenya and Arbagio. It's to compare effectiveness of the meds, but also because the 2 doc presented the same proposal requesting very close screening of MS patients.

    The study consist of monthly 3D-MRIs, blood work to screen for those ineligible for Arbagio and monthly? blood work and MS Neuro office visit, and cost of Arbagio.

    There are 2 MS clinics included in the study, Harvard and my MS clinic doc.

    I'm real apprehensive about stopping Ty, but my doc's practice is going in another DMT direction it seems.

    I would like to hear from anyone who is or will be participating in this study. I assume wer're a small group represented here because of the limited scope of the study.
    Anyone else participating in the study?
Working...
X